Literature DB >> 1688886

Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes.

T G Parker1, S E Packer, M D Schneider.   

Abstract

Cardiac-specific gene expression is intricately regulated in response to developmental, hormonal, and hemodynamic stimuli. To test whether cardiac muscle might be a target for regulation by peptide growth factors, the effect of three growth factors on the actin and myosin gene families was investigated by Northern blot analysis in cultured neonatal rat cardiac myocytes. Transforming growth factor-beta 1 (TGF beta 1, 1 ng/ml) and basic fibroblast growth factor (FGF, 25 ng/ml) elicited changes corresponding to those induced by hemodynamic load. The "fetal" beta-myosin heavy chain (MHC) was up-regulated about four-fold, whereas the "adult" alpha MHC was inhibited greater than 50-60%; expression of alpha-skeletal actin increased approximately two-fold, with little or no change in alpha-cardiac actin. Thus, peptide growth factors alter the program of differentiated gene expression in cardiac myocytes, and are sufficient to provoke fetal contractile protein gene expression, characteristic of pressure-overload hypertrophy. Acidic FGF (25 ng/ml) produced seven- to eightfold reciprocal changes in MHC expression but, unlike either TGF-beta 1 or basic FGF, inhibited both striated alpha-actin genes by 70-90%. Expression of vascular smooth muscle alpha-actin, the earliest alpha-actin induced during cardiac myogenesis, was increased by all three growth factors. Thus, three alpha-actin genes demonstrate distinct responses to acidic vs. basic FGF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688886      PMCID: PMC296452          DOI: 10.1172/JCI114466

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  56 in total

1.  Transformation by activated ras or fos prevents myogenesis by inhibiting expression of MyoD1.

Authors:  A B Lassar; M J Thayer; R W Overell; H Weintraub
Journal:  Cell       Date:  1989-08-25       Impact factor: 41.582

2.  Epithelial-mesenchymal cell transformation in the embryonic heart can be mediated, in part, by transforming growth factor beta.

Authors:  J D Potts; R B Runyan
Journal:  Dev Biol       Date:  1989-08       Impact factor: 3.582

3.  Decrease in transforming growth factor-beta binding and action during differentiation in muscle cells.

Authors:  D Z Ewton; G Spizz; E N Olson; J R Florini
Journal:  J Biol Chem       Date:  1988-03-15       Impact factor: 5.157

4.  Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.

Authors:  W E Wright; D A Sassoon; V K Lin
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

5.  Ca2+ and Na+ currents in developing skeletal myoblasts are expressed in a sequential program: reversible suppression by transforming growth factor beta-1, an inhibitor of the myogenic pathway.

Authors:  J M Caffrey; A M Brown; M D Schneider
Journal:  J Neurosci       Date:  1989-10       Impact factor: 6.167

6.  Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene.

Authors:  J N Buskin; S D Hauschka
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

7.  Mitogens and oncogenes can block the induction of specific voltage-gated ion channels.

Authors:  J M Caffrey; A M Brown; M D Schneider
Journal:  Science       Date:  1987-05-01       Impact factor: 47.728

8.  Inhibition of myogenic differentiation by the H-ras oncogene is associated with the down regulation of the MyoD1 gene.

Authors:  S F Konieczny; B L Drobes; S L Menke; E J Taparowsky
Journal:  Oncogene       Date:  1989-04       Impact factor: 9.867

9.  Control by fibroblast growth factor of differentiation in the BC3H1 muscle cell line.

Authors:  B Lathrop; E Olson; L Glaser
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

10.  Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice.

Authors:  N L Thompson; K C Flanders; J M Smith; L R Ellingsworth; A B Roberts; M B Sporn
Journal:  J Cell Biol       Date:  1989-02       Impact factor: 10.539

View more
  89 in total

1.  Regulation of Na/K-ATPase beta1-subunit gene expression by ouabain and other hypertrophic stimuli in neonatal rat cardiac myocytes.

Authors:  P Kometiani; J Tian; J Li; Z Nabih; G Gick; Z Xie
Journal:  Mol Cell Biochem       Date:  2000-12       Impact factor: 3.396

2.  Serial killer: angiotensin drives cardiac hypertrophy via TGF-beta1.

Authors:  Michael D Schneider
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  Fibroblast Growth Factor 2 Mediates Isoproterenol-induced Cardiac Hypertrophy through Activation of the Extracellular Regulated Kinase.

Authors:  Stacey L House; Brian E House; Betty Glascock; Thomas Kimball; Eyad Nusayr; Jo El J Schultz; Thomas Doetschman
Journal:  Mol Cell Pharmacol       Date:  2010

4.  Effects of subcultivation and culture medium on differentiation of human fetal cardiac myocytes.

Authors:  B I Goldman; J Wurzel
Journal:  In Vitro Cell Dev Biol       Date:  1992-02

5.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

6.  FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality.

Authors:  Victoria Shalhoub; Edward M Shatzen; Sabrina C Ward; James Davis; Jennitte Stevens; Vivian Bi; Lisa Renshaw; Nessa Hawkins; Wei Wang; Ching Chen; Mei-Mei Tsai; Russell C Cattley; Thomas J Wronski; Xuechen Xia; Xiaodong Li; Charles Henley; Michael Eschenberg; William G Richards
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

7.  Aging and Cardiac Fibrosis.

Authors:  Anna Biernacka; Nikolaos G Frangogiannis
Journal:  Aging Dis       Date:  2011-04       Impact factor: 6.745

Review 8.  Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues.

Authors:  Nicole T Feric; Milica Radisic
Journal:  Adv Drug Deliv Rev       Date:  2015-05-05       Impact factor: 15.470

9.  p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.

Authors:  Felix B Engel; Michael Schebesta; Mychelle T Duong; Gang Lu; Shuxun Ren; Jeffery B Madwed; Huiping Jiang; Yibin Wang; Mark T Keating
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

10.  Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors.

Authors:  T G Parker; K L Chow; R J Schwartz; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.